Delayed Graft Dysfunction due to Invasive Hepatic Mucormycosis After Living Donor Liver Transplantation [0.03%]
肝移植后供肝延迟性功能障碍并发侵袭性肝毛霉病病例报告
Rohan J Chaudhary,Narendra S Choudhary,Neeraj Saraf et al.
Rohan J Chaudhary et al.
Mucormycosis is a rare but emerging fungal infection complicating solid organ transplantation. It is associated with a high mortality rate. We describe an unusual case of hepatic mucormycosis in a living donor liver transplant recipient pre...
Clinical Profile and Efficacy of Antivirals in Hepatitis B Virus Reactivation, in Patients With Cancer Receiving Chemotherapy [0.03%]
肿瘤患者化疗过程中乙肝病毒再激活的临床特点和抗病毒治疗疗效分析
Manzoor A Wani,Jaswinder S Sodhi,Ghulam N Yatoo et al.
Manzoor A Wani et al.
Background/purpose: Hepatitis B virus reactivation (HBVR) is common in patients withcancer. The aim of the present study was to find out clinical profile of patients with cancer receiving chemotherapy with HBVR and to stu...
Lower Likelihood of Post-transplant Graft Failure, Death, and Retransplantation in the Era of Direct-Acting Antivirals [0.03%]
直接抗病毒药物时代移植后移植物功能衰竭、死亡和再次移植的风险降低
Kellie Young,Benny Liu,Taft Bhuket et al.
Kellie Young et al.
Background: Direct-acting antivirals (DAAs) are expected to improve outcomes for patients with hepatitis C virus (HCV) infection after liver transplantation (LT). We aim to evaluate trends in post-LT outcomes with availab...
Serum Leptin Serves as an Inflammatory Activity Marker and Predicts Steroid Response in Autoimmune Hepatitis [0.03%]
血清瘦素用作炎症标志物可预测自身免疫性肝炎的类固醇治疗反应
Deepika Lal,Monika Thakur,Chhagan Bihari
Deepika Lal
Background and aim: Adipocytokines, especially leptin is involved in a wide spectrum of proinflammatory functions, in various tissues. This study was carried out to assess the role of serum leptin in autoimmune hepatitis....
Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation-Mid- and Long-Term Outcomes [0.03%]
射频消融治疗早期肝细胞癌的中期和长期疗效分析
Amar Mukund,Prayas Vats,Ankur Jindal et al.
Amar Mukund et al.
Background: Radiofrequency ablation (RFA) is a standard treatment for small inoperable hepatocellular carcinoma (HCC). Studies on mid- and long-term outcome of RFA as first-line therapy for HCC from India are limited. ...
Telemedicine Improves Access to Hepatology Consultation with High Patient Satisfaction [0.03%]
远程医疗提高了肝病会诊的访问率并使患者满意度提高
Ezequiel Mauro,Sebastián Marciano,María C Torres et al.
Ezequiel Mauro et al.
Aims: Telemedicine between health care providers could be useful for improving the access to hepatology consultations, which is challenging in some regions. The primary objective of this study was to estimate the proporti...
Hepatitis B Reactivation in Liver Transplant Recipients With Hepatitis B Virus Core Antibody Positive Grafts: a Retrospective Study [0.03%]
乙型肝炎核心抗体阳性供肝的肝脏移植受者中乙型肝炎再激活：一项回顾性研究
Benjamine Khiangte,Sunil R Kothakota,Madhu Sasidharan et al.
Benjamine Khiangte et al.
Background: Liver grafts from hepatitis B core antibody (anti-HBc) positive donors increase the risk of hepatitis B virus (HBV) reactivation in recipients due to posttransplant immunosuppressive therapy. ...
Pramod Kumar,Anand Kulkarni,Mithun Sharma et al.
Pramod Kumar et al.
Acute liver failure secondary to yellow phosphorus rodenticide poisoning: Outcomes at a center with dedicated liver intensive care and transplant unit [0.03%]
黄磷灭鼠剂中毒所致急性肝功能衰竭：设有专门肝病重症监护和移植单元的中心中的预后情况
Ravi Mohanka,Prashantha Rao,Mitul Shah et al.
Ravi Mohanka et al.
Accidental or suicidal poisoning with yellow phosphorus or metal phosphides (YPMP) such as aluminum (AlP) zinc phosphide (Zn3P2) commonly cause acute liver failure (ALF) and cardiotoxicity. These are used as household, agricultural and indu...
Restructuring Living-Donor Liver Transplantation at a High-Volume Center During the COVID-19 Pandemic [0.03%]
COVID-19大流行期间高量级中心生活捐赠者肝移植的重组
Arvinder S Soin,Narendra S Choudhary,Sanjay K Yadav et al.
Arvinder S Soin et al.
Background: Coronavirus disease 2019 (COVID-19) pandemic has led to deferral of elective transplants and proactive pretransplant testing of the donor/recipient. The impact of these on living-donor liver transplantation (L...